Asia electronics group Samsung is looking to gain greater control of the organic light-emitting diode, or OLED, technology as consumers favour thinner screens in smartphones and TV sets. It is hoping to get a piece of that market through a pending acquisition through its affiliate Cheil Industries, also known as Samsung Chemical, of German organic light-emitting diode (OLED) technology developer Novaled.

Green Molecular, a spin-out of the University of Valencia, licences its pharma tech to cosmetics firm ChromaDex.

Humboldt spin-out Tame tunes up ahead of public launch.

Samsung looks to acquire LED manufacturer Novaled for over $200m.

The Munich University Hospital completes new radiopharmaceutical centre in co-operation with University of Erlangen spin-out PET Net.

Edimer Pharmaceuticals raises $18m series B financing led by New Enterprise Associates and including new investor Sanofi-Genzyme BioVentures.

University of Manchester scientists working on an app for psychosis therapy receive government funding.

US-based Crown Bioscience acquires Nottingham oncology spin-out.

Oilfield services firm Schlumberger acquires Calgary spin-off Gushor.